Targeted Medical Pharma (Targeted Medical Pharma) GF Value : $0.00 (As of May. 05, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Targeted Medical Pharma GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-05), Targeted Medical Pharma's share price is $0.0001. Targeted Medical Pharma's GF Value is $0.00. Therefore, Targeted Medical Pharma's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Targeted Medical Pharma is Not Valued.

Targeted Medical Pharma (OTCPK:TRGM) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Targeted Medical Pharma's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.0001	/	0.00
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Targeted Medical Pharma GF Value Related Terms

Thank you for viewing the detailed overview of Targeted Medical Pharma's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Targeted Medical Pharma (Targeted Medical Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Targeted Medical Pharma Inc (OTCPK:TRGM) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2980 Beverly Glen Circle, Los Angeles, CA, USA, 90077

Website

http://www.tmedpharma.com

Targeted Medical Pharma Inc is a United States based specialty pharmaceutical company, which develops and commercializes amino acid-based medications. The business activities of the group are functioned through Targeted Medical Pharma; Complete Claims Processing, Inc. and Amino Nutritionals segments. The operations of the group are primarily functioned through the region of United States and it derives the majority of revenue from Targeted Medical Pharma segment which develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers through employed sales representatives, independent distributors, and pharmacies.

Executives

William B. Horne	officer: Chief Financial Officer	C/O AULT ALLIANCE, INC., 940 SOUTH COAST DRIVE, SUITE 200, COSTA MESA CA 92626
Maurice J Dewald	director	C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 100, LOS ANGELES CA 90077
Scott Gottlieb	director	MOLECULAR INSIGHT PHARMACEUTICALS, 160 SECOND STREET, CAMBRIDGE MA 02142
Ronald W Rudolph	officer: See Remarks	C/O TARGETED MEDICAL PHARMA, INC, 2980, BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Amir F Heshmatpour	director, 10 percent owner, officer: Former President	C/O AFH HOLDING & ADVISORY LLC, 9595 WILSHIRE BLVD, STE 900, BEVERLY HILLS CA 90212
John H Bluher	director	12981 NORTH 2ND STREET, PARKER CO 80134
Steve B Warnecke	officer: Chief Financial Officer	C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Afh Holding & Advisory, Llc	10 percent owner, other: Former 10% Owner	269 S. BEVERLY DRIVE, STE #1600, BEVERLY HILLS CA 90212
Timothy Brasel	director, officer: Vice President	16178 EAST PRETENCE PLZ, AURORA CO 80015

Targeted Medical Pharma (Targeted Medical Pharma) Headlines

No Headlines